POSTER PRESENTATIONGuidelines

OVERVIEW Poster sessions are designed to give presenters an opportunity to discuss informally their research with colleagues interested in their research. The purpose of the posters is to visually stimulate interest in the research, to present sufficient information for view- 21st ers to understand the methods, results, and signifi- cance of the research, and to promote conversations and networking among conference participants. ICPE August 21-24, 2005 POSTER SESSION Gaylord Opryland Resort and Convention Posters will be displayed in Ryman Exhibit Hall. Each session is for one day: Center, Nashville, TN

Monday, August 22, Poster Session A Tuesday, August 23, Poster Session B NUMBERING SYSTEM Wednesday, August 24, Poster Session C Each poster board will be numbered. The poster number is the first number listed. 1. Set Up Presenters should attach their posters to the 7:00am-8:15am. All posters must be up by 8:15am. board number corresponding to the number assigned to their poster in the final program, 2. Open which will be available at the registration Ryman Exhibit Hall will be open from: desk. Please note the number may differ from 7:00am - 5:00pm, Monday and Tuesday, and that shown in the preliminary program. The 7:00am -1:30pm Wednesday. abstract number, for use in locating abstracts in the final program and the special issue of All food functions (continental breakfasts, breaks Pharmacoepidemiology and Drug Safety, is in and lunches) as well as exhibits will be located brackets [xxx] after the title of the abstract. in Ryman Exhibit Hall. POSTER SPECIFICATIONS 3. Discussion Time 1. Posters must be designed to fit a space 4 Presenters should be at their poster between feet high by 8 feet wide. Vertical posters 12:15-1:15pm to discuss their posters with will not fit the boards; only horizontal interested viewers. posters are allowed. The board will be the only support device available. Business 4. Take Down cards or small leaflet literature for distribu- All posters must be taken down by 6:00 pm on tion may be inserted in an envelope and Monday and Tuesday; posters must be taken affixed to the board. Poster orientation: down by 2:00pm on Wednesday. Landscape.

NOTE: Neither ISPE or the Opryland Resort & 2. Posters may be attached to the boards by Convention Center will be responsible for any poster pushpins or male Velcro. Please bring your that is left up overnight or is lost or damaged. own mounting supplies.

27 August 21-24, 2005 | Gaylord Opryland Resort and Convention Center | Nashville, TN POSTER SESSION A | MONDAY, AUGUST 22, 2005

1 Non-Steroidal Anti-Inflammatory 10 Survey of Disability, Medication Use, and 20 Incidence and Prevalence of Medication: Do Medical Records Agree Medication Satisfaction among Members Antipsychotic Use in Non- with Patient Self Report? [1] with Rheumatoid Arthritis of a Large Institutionalised Patients in 1993-2003 Maziar Abdolrasulnia, Nelson Weichold, Health Care Plan Database [10] [20] Linda L Casebeer, Norm W Weissman, P Mona Eng, Catherine B Johannes, Claire C Gerard WK Hugenholtz, Eibert R Heerdink, Kenneth G Saag, Jeroan Allison. (United Chaing, William A West, John D Seeger, Willem A Nolen, Toine CG Egberts. States) Alexander M Walker. (United States) (Netherlands)

2 Detection and Treatment of Hypertension 11 The Influence of Environmental 21 Monitoring of Vaccine Safety Inquiries: A in General Health Care Practice. A Temperature on Lithium Serum Levels [11] New Tool for Vaccine Safety Signal Patient-Based Study [2] Sandra Fase, Ingeborg Wilting, Eibert R Generation [21] Ahmad Al-Windi. (Sweden) Heerdink, Willem A Nolen, Toine CG Elaine R Miller, John K Iskander, Penina Egberts. (Netherlands) Haber, Paul Gangarosa, Vitali Pool, Robert T 3 Patterns of Discontinuation, Dose Chen. (United States) Modification and Switching among Users 12 A Study of the Use of Cisapride Analyzed of Prescription Non-Steroidal Anti- from the Claim Database of National 22 Utilization Patterns of Pharmaceutical Inflammatory Drugs (NSAID) Including Health Insurance Program in Taiwan [12] and Herbal Medicine in Pregnancy and Cyclo-Oxygenase 2 Inhibitors (COX-2) in Churn-Shiouh Gau, I-Shou Chang, Fei-Lin Lactation [22] a UK Population [3] Lin Wu, Hui-Tzu Yu, Yu-Wen Huang, Cheng- Sigal Kaplan, Sheila Weiss Smith. (United Felix M Arellano, Charles E Wentworth, Liang Chi, Su-Yu Chien, Keh-Ming Lin, Hui- States) Corey May, Anila Verma, Javier Cid. (United Po Wang. (Taiwan) States) 23 Association of Dual Use of Over-the- 13 Comparative Safety of Colloids: Results of a Counter and Prescription Non-Steroidal 4 The International Diabetes Management Disproportionality Analysis (DA) [13] Anti-Inflammatory Drugs (NSAIDs) with Practices Study (IDMPS): Methodology Manfred Hauben, Charles M Gerrits, Lester Health-Related Quality of Life [23] and First Results of the Pilot Study [4] Reich. (United States) Stacey H Kovac, Kenneth G Saag, Jeffrey R Cecile Beden, Pablo Aschner, Juan Jose Curtis, Jeroan Allison. (United States) Gagliardino, Nicolae Hancu, Patrick 14 Comparative Performance of Proportional Sinassamy. (France) Reporting Ratios (PRR) and Multi-Item 24 Impact of Consumer-Initiated Adverse Gamma Poisson Shrinker (MGPS) for the Event Reports on Case Volume and Report 5 Regional Differences in Suicide Rate and Identification of Crystalluria and Urinary Source Distribution [24] Use of Lithium in Norway [5] Tract Calculi Caused by Drugs [14] Ed Keystone, Haiying Liu, Atsuko Shibata, Jorgen G Bramness, Fredrik Walbye, Manfred Hauben, Lester Reich, Charles M Wayne Wallis, Sean Zhao. (United States) Svetlana Skurtveit, Aa Tverdal. (Norway) Gerrits. (United States) 25 A Systematic Review and Critical 6 A Contribution to the Rational Use of 15 Prevalence of Osteoarthritis and Evaluation of Risk-Benefit Analysis Contraceptive Methods among Female Rheumatoid Arthritis: Cross-Sectional Methods for Therapeutic Interventions Adolescent Students in Campo Grande, Analysis in a Follow up Study [15] [25] MS, Brazil [6] Antonio González-Pérez, Luis A García Larry D Lynd, Mark J Sculpher, Andrew R Valdir S Siroma, Lia LC Castro. (Brazil) Rodríguez, Saga Johansson, Mari-Ann Willan, Megan E Coombes. (Canada) Wallander. (Spain) 7 Making Medical Injection Safer: A Major 26 Healthcare Spending and Use for the Top Step towards Enhancing Patient Safety in 16 Drug Utilization and Market-Share 5 Conditions among United States Developing Countries [7] Competition among Antipsychotics in US Community Dwelling Adults: Findings Robert T Chen, Glenn Post, Jules Millogo, Medicaid Programs [16] from the Medical Expenditure Panel Karen Van Roekel, Mary Catlin, Ken Clark. Jeff J Guo, Christine ML Kelton, Yan Chen, Surveys 1997-1998 and 2000-2001 [26] (United States) Yonghua Jing, Nick Patel. (United States) Margaret McDonald, Robin P Hertz, Alan N Unger, Michael B Lustik, Jeffrey A Cornell. 8 Association of Caffeine Concentrations 17 Consumers Usurp Spontaneous Adverse (United States) with Fasting Glucose Levels in Caffeine- Event Reporting in the United States [17] Drug Users and Nonusers — Results of Isaac W Hammond, Donna Rich. (United 27 Antihypertensive Medication Use in German National Health Surveys from States) Newly-Aware Hypertensives [137] 1984 to 1999 [8] C Ineke Neutel, Norm Campbell, Lisa Yong Du, Hans-Ulrich W Melchert, Hildtraud 18 Quality of Data Provided to Physicians by Pogany, Leslie Gaudette (Canada) Knopf, Ellen Pabel. (Germany) Dietary Supplement Manufacturers in Support of Safety and Efficacy Claims [18] 28 What Is the Justification for Long-Term 9 Antidepressant Use during Pregnancy and David J Hass, James D Lewis. (United States) Benzodiazepine Use? [28] Potential Neonatal Adverse Effects: Impact C Ineke Neutel (Canada) of a Health Canada Advisory and 19 Cardiovascular Risk Factors at Baseline Subsequent Reports in the News Media [9] and Cardiovascular Events in Patients 29 Social Circumstances Adverse Event Terms Adrienne Einarson, Anne-Marie with Metastatic Breast Cancer Receiving in MedDRA: Extent of Coding and Potential Schachtschneider, Roland Halil, Enkelejde Hormone- or Chemotherapy [19] Impact on Signal Detection [29] Bollano, Koren Gideon. (Canada) Nancy S Breekveldt-Postma, Myrthe Sukel, Manfred Hauben, Vaishali K Patadia. Joëlle A Erkens, Annette B Beiderbeck, Ron (United States) MC Herings. (Netherlands)

28 21st ICPEInternational Conference on Pharmacoepidemiology & Therapeutic Risk Management POSTER SESSION A | MONDAY, AUGUST 22, 2005

30 Potentially Inappropriate Prescribing for 41 Prevalence and Factors Associated with 50 Effectiveness of Antipsychotic Older Veterans: The Impact of Healthcare the Offlabel Use of Antipsychotic, Treatments in a Nation-Wide Cohort of System Factors [30] Antidepressant and Anticonvulsant 2230 Patients in Community Care after Mary Jo V Pugh, B Graeme Fincke, Arlene Medications among Georgia Medicaid the First Hospitalization Due to Bierman, Francesca Cunningham, Dan R Eligibles in 2001 [41] Schizophrenia and Schizoaffective Berlowitz. (United States) Hua Chen, Bradley C Martin. (United States) Disorder [50] Jari K Haukka, Jari Tiihonen, Timo Klaukka, 31 Pregnancy Registries: Streamlining 42 Use of Propensity Scores To Identify Kristian Wahlbeck, Jouko Lönnqvist. (Finland) Regulatory Requirements To Increase Possible Medication Dispensing Errors Enrollment [31] among Patients with Alzheimer’s Disease 51 Retrospective Cohort Study on Relationship Susan S Roberts, Deborah L Covington, [42] between Short-Term Fever of Unexplained Peggy A Doi. (United States) J Alexander Cole, Shao Zhu, Leo J Russo, Origin and Tianbaokang or Purun Daniel Fife, Alexander M Walker. (United Injection(Puerarin Injection) [51] 32 Is Spontaneous Adverse Event Reporting States) Xue-rong Huang, Rong-yuan Zheng, Xi-jia Stimulated by DTCA? Experience from a Wang, Xiu-hua Zhang, Rong Jin. (China) Low-Dose Oral Contraceptive [32] 43 Use of Beta-Blockers and Risk of Hip and Sonal S Shah, Ana Aymes, Georgia Lehnert, Vertebral Fracture: Relationships to Daily 52 Analgesic Use in Early Pregnancy [52] Robyn Jones, Patrick Caubel. (United and Cumulative Dose [43] Michele L Jonsson Funk, Katherine E States) Frank De Vries, Patrick C Souverein, Marie L Hartmann. (United States) De Bruin, Hubert GM Leufkens, Cyrus 33 Utilisation Patterns of Over-the-Counter Cooper, Tjeerd P Van Staa. (Netherlands) 53 Who’s Watching the Safety of OTC Emergency Contraception [33] Drugs—and How? [53] Sinikka Sihvo, Heidi Oksama, Kirsi Pietila, 44 Risk of Clinical Fractures after Lynn Rosenberg, David W Kaufman, Allen A Elina Hemminki. (Finland) Gonadotropin-Releasing Hormone (GnRH) Mitchell. (United States) Agonist Therapy for Non-Metastatic 34 Who, Where, and What in Spontaneous Prostate Cancer [44] 54 Case-Control Study on the Association of Reports [34] Matthew R Smith, Simone Peart Boyce, Upper Gastrointestinal Bleeding and Kristina Star, Marie Lindquist. (Sweden) Erick Moyneur, Mei Sheng Duh, Monika K Non-Steroidal Anti-Inflammatory Drugs Raut, Jane Bradman, Jennifer C Sung. in Japan [54] 35 Predictive Value of a Computerized Signal (United States) Kiyoshi Kubota, Tsugumichi Sato, Akira Detection Algorithm (MGPS) When Terano, Kentaro Sugano, Choitsu Sakamoto, Applied to FDA AERS Database [35] 45 Incidence of Selected Outcomes among Shinichi Ota, Susana Perez-Gutthann, David Manfred Hauben, Louisa Walsh, Lester Matched Cohorts of Initiators of Racemic W Kaufman. (Japan) Reich. (United States) Zopiclone, Temazepam, and Zolpidem in the General Practice Research Database [45] 55 Impact of Exception Drug Status on the 36 A Retrospective Analysis of Morbidity P Mona Eng, Najat Ziyadeh, Beth L Appropriate Use of TZDs [55] Associated with Coded Postoperative Nordstrom, Judy Caron, David Amato, John Marc Dorais, Jacques LeLorier. (Canada) Ileus among Open Laparotomy Bowel D Seeger. (United States) Surgery Patients [36] 56 Do Statins Induce Higher Risk of Rachel E Williams, Timothy J Bell, Peter 46 Cancer Risk among Danish Women with Myopathy in Patients with Wang, William B Saunders. (United States) Silicone Breast Implants [46] Hyperlipidemia [56] Soren Friis, Lisbet R Hölmich, Joseph K Mei-Shu Lin, Nen-Chung Chang, Yen-Hui 37 Post-Licensure Safety Surveillance for McLaughlin, Jon P Fryzek, Trine Henriksen, Chen, Yea-huei Kao Yang. (Taiwan) Recombinant Human Coagulation Factor Jørgen H Olsen. (Denmark) VIIa [37] 57 Safety Profile of Tacrolimus Ointment as Jennifer J Wood, Kathyrn A O’Connell, 47 Epidemiology and Treatment Patterns of Used in General Practice in England: Robert P Wise. (United States) Psoriasis in the General Practice Research Interim Results of an Ongoing Database (GPRD) [47] Prescription-Event Monitoring Study [57] 38 Cognitive Impairment Associated with H2 Joel M Gelfand, Xingmei Wang, Qing Liu, Vanessa Marshall, Lynda V Wilton, Saad AW Receptor Antagonists in a Community- Andrea Neiman, Rachel Weinstein, David J Shakir. (United Kingdom) Based Sample of Elderly African Margolis, Andrea B Troxel. (United States) Americans [38] 58 New Users of Inhaled Corticosteroids Hisham S Aljadhey, Michael D Murray, 48 The Association between p.r.n. (As- (ICS) in the United Kingdom Have Higher Kathleen A Lane, Sujuan Gao, Kathleen S Needed) Medication and Aggressive Probability of Continuous Use Than New Hall, Hugh Hendrie. (United States) Incidents in Psychiatric Inpatients [48] Users in the Netherlands [58] Laurette E Goedhard, Joost J Stolker, Eibert Tanja T Menckeberg, Jitka Pokladnikova, 39 Medications and Pregnancy: A R Heerdink, Henk LI Nijman, Toine CG Marcel L Bouvy, Svetlana V Belitser, Population-Based Study [39] Egberts. (Netherlands) Madelon Bracke, Jan AM Raaijmakers, Anick Bérard, Élodie Ramos, Lucie Blais, Hubert GM Leufkens. (Netherlands) Djamal Berbiche. (Canada) 49 Evaluation of an Automated Risk Score for Determining the Risk for NSAID- 59 Lymphoma Risk in Patients with 40 Interim Results from a Modified Event Related Gastrointestinal Events Using Rheumatoid Arthritis Who Received 2 or Monitoring Study of Travoprost as Used Pharmacy Data [49] More Disease Modifying Anti-Rheumatic in Primary Care in England [40] Maarten J ten Berg, Wim G Goettsch, Peter Drugs (DMARDs): A Retrospective Cohort Andrew J Boshier, Lynda V Wilton, Saad AW AGM de Smet, Ron MC Herings. Study in the GPRD [59] Shakir. (United Kingdom) (Netherlands) Daniel I Mines, Laura A Novelli, Holly Yu. (United States) 29 August 21-24, 2005 | Gaylord Opryland Resort and Convention Center | Nashville, TN POSTER SESSION A | MONDAY, AUGUST 22, 2005

60 Temporal Relationship between Non- 69 Determinants of Suboptimal 79 Lower and Upper Bounds on the Steroidal Anti-Inflammatory Drugs / COX- Antidepressant Use in the Elderly: Are Correlation between Treatment and 2 Inhibitors and Cardiovascular Risk – A Patient or Physician Factors More Instrumental Variable Limit the Retrospective Analysis Using the Veteran Important? [69] Applicability of the Method [79] Affairs (VA) Database [60] Philip S Wang, M Alan Brookhart, Sebastian Edwin P Martens, Wiebe R Pestman, Ton de Stephen P Motsko, Karen L Rascati, Jamie C Schneeweiss, Jerry Avorn, Robert J Glynn, Boer, Svetlana V Belitser, Olaf H Klungel. Barner, Anthony J Busti, James P Wilson, Amanda Patrick, Daniel H Solomon. (United (Netherlands) Kenneth A Lawson. (United States) States) 80 Differential Risks of Death for Users of 62 The WHI Publication: What Are the 70 Persistence, Compliance and Adherence Carvedilol According to the Specialty of Changes in Pattern of HRT Use and the to Statins: A Comparison of “Treat to the Prescriber [80] Persistence Rate? [62] Target” and “Fire and Forget” Treatment Marc Dorais, Jacques LeLorier. (Canada) Marie Pascale Guay, Alice Dragomir, Yola Strategies [70] Moride, Sylvie Perreault. (Canada) Li Wei, Thomas M MacDonald, Michael J 81 Comparison of Three Methods in Causality Murphy. (United Kingdom) Assessment: Expert Judgement, French 63 Racial Differences in Medications Used in Algorithm and Logistic Method [81] 71 Risk of Adverse Pregnancy Outcome after African American Compared to White Helene Theophile, Yannick Arimone, Maternal Use of Fluoroquinolone [71] Young Adults from a Population-Based Francoise Haramburu, Ghada Miremont- Pia Wogelius, Mette Nørgaard, Mette Sample: The CARDIA Study [63] Salame, Nicholas Moore, Annie Fourrier- Gislum, Henrik Carl Schønheyder, Henrik Maribel Salas, O Dale Williams, Lucia Juarez, Reglat, Bernard Begaud. (France) Toft Sørensen. (Denmark) Yongin Kim, Sharina D Person, Catarina Kiefe. (United States) 72 Testing the Feasibility of Using an 82 ASSIGN: A Proactive Systematic Approach Administrative Medical Claims Database to Vaccine-Vigilance in the U.S. Vaccine 64 Drugs Associated with QTc Prolongation To Study the Pharmacogenetics of a Rare Adverse Event Reporting System [82] and Torsade de Pointes [64] Adverse Event [72] Vitali Pool, Steve P James, Robert T Chen. Sabine MJM Straus, Miriam CJM Thanos I Zavras, Donnie P Funch, Jared D (United States) Sturkenboom, Cornelis S Cornvan der Hooft, Danielson, Cheryl A Farello, Julian B Jan A Kors, Albert Hofman, J Herre Kingma, Arbuckle, Edward L Murrelle. (United States) 83 Predictors of Heart Failure in COPD Jacqueline CM Witteman, Bruno HCh Medicaid Patients [83] Stricker. (Netherlands) 73 Cost-Effectiveness of Increasing Influenza Antoine C El Khoury, Fadia T Shaya, Weir R Vaccination Rate by Community Matthew. (United States) 65 Safety of Drugs Prescribed during Pharmacists Advocating Immunization [73] Pregnancy in Russia: A Way Far from Takashi Usami, Masayuki Hashiguchi, 84 Studying Co-Medication Patterns Using Advised Standards [65] Tsuyoshi Kouhara, Akira Ishii, Taizou Large Databases [84] Elena A Strizhenok, Leonid S Stratchounski. Nagata, Mayumi Mochizuki. (Japan) Hilde Tobi, Adrianne Faber, Paul B van den (Russian Federation) Berg, J Wanzer Drane, Lolkje TW de Jong- 74 Use of Post-Market Safety Surveillance van den Berg. (Netherlands) 66 Case-Control Study of the Association Data To Detect Drug Interactions: Drug A between Use of Acid Suppression Drugs and Coumadin [74] 85 Outpatient Pharmacist’s Interventions in and Risk of Gastric Cancer [66] Isaac W Hammond. (United States) Sultan Qaboos University Hospital, Oman Hani M Tamim, Andre Duranceau, Long-Qi [85] Chen, Jacques LeLorier. (Canada) 75 Methodological Aspects and Contents of Waiel Al-Naeem, Aqeela Taqi, Issa Al- the Pharmacoepidemiological Rashdi, Kassim Al-Riyamy. (Oman) 67 A Prospective Cohort Study of Patients Questionnaire for Children and with HER-2 Positive Metastatic Breast Adolescents - KiGGS-Survey of the Robert 86 Disease Management Programs Targeting Cancer: Report of Recruitment and Data Koch-Institute in Germany [75] Asthma and Chronic Obstructive Collection Methods in the registHER Hans-Ulrich W Melchert, Hildtraud Knopf, Ellen Pulmonary Disease Patients: A Systematic Experience [67] Pabel, Marianne Braemer-Hauth. (Germany) Review and Meta-Analysis [86] Marianne E Ulcickas Yood, Wei Dong, Jin Enkhe Badamgarav, Anacleto Gano, Jr., 76 Therapeutic Risk Management: A Case Wang, James Reimann, Pavel Napalkov, Suellen Curkendall. (United States) Study of Recombinant Human Virginia Paton. (United States) Erythropoietin Therapy among Renal 87 Changes in the Utilization of Oral Failure Patients [76] 68 Non-Steroidal Anti-Inflammatory Drugs and Antidiabetic Drugs between 1998 and Dennis J Cotter, Mae Thamer, Yi Zhang, the Risk of Ageing Macular Disease [68] 2004 in Hungary [87] Kevin Stefanik. (United States) Annemieke M van Kints, Katia MC Peter Doro, Edit Kosik, Maria Matuz, Verhamme, Sharmila Boekhoorn, Miriam Gyongyver Soos. (Hungary) 77 Redundancy: A Discrepancy between CJM Sturkenboom, Bruno Ch Stricker. What We Want and What We Get from (Netherlands) 88 Pharmacoepidemiogenomics: New Our Effect Estimates [77] Paradigm in Pharmacoepidemiology [88] Nicolle M Gatto, Ulka B Campbell. (United Pendar Farahani, Mitchell Levine. (Canada) States)

78 Applying Multinomial Logistic Regression 89 Diabetes Mellitus Associated with in Hypertensive Patients [78] Atypical Antipsychotic Use among Ana P Ferreira, Jose P Guerreiro, Maria F Patients with Bipolar Disorders in a Large Oliveira. (Portugal) Managed Care Population [89] Jeff J Guo, Paul E Keck, Jr., Hong Li, Raymond Jang, Williams Carson. (United States) 30 21st ICPEInternational Conference on Pharmacoepidemiology & Therapeutic Risk Management POSTER SESSION B | TUESDAY, AUGUST 23, 2005

90 The Menopause Rating Scale (MRS) as 1 Patient Access to and Utilization of 12 Illustrating Trends and Costs of Outcome Measure for Hormone Treatment Prescription Drugs in the Saudi Ministry Antihypertensives Using the Medical [90] of Health Hospital Outpatient Clinics [150] Expenditure Panel Survey, an Underused Lothar AJ Heinemann, Juergen Dinger. Mohamed A Alkelya, David H Kreling. Resouce in Pharmacoepidemiology [161] (Germany) (United States) Douglas Gause, Craig Plauschinat. (United States) 91 Economic Evaluation of Sirolimus-Eluting 2 Contribution of Latin America to Stents in Japan [91] Pharmacovigilance: Analysis of the 13 Cornfield’s Condition Applied to Data Mia Kobayashi, Shunya Ikeda. (Japan) Literature [151] Mining Output To Ascertain Confounding Victoria E Arango, Camilo J Gonzalez, [162] 92 Who Are Statin Users in the Community? Thomas R Einarson. (Canada) Manfred Hauben, Charles M Gerrits, Lester (A Canadian Experience) (Preliminary Reich. (United States) Report) [92] 3 Increase in Prevalence of Antidepressant Pendar Farahani, Kathryn Gaebel, Jacques Use in Quebec within All Age Groups and 14 Pituitary Apoplexy Associated with LeLorier, Sylvie Perrault, Jane Gillis, Judith Persons Diagnosed with Depression, Leuprolide, Goserelin and Triptorelin [163] Soon, Mitchell Levine. (Canada) Panic or Generalized Anxiety Disorders Paula Gish, Carolyn A McCloskey, Mark [152] Avigan. (United States) 93 Patterns of Analgesic Use for Louise Barnard. (Canada) Musculoskeletal Disorders in Rural 15 Survey of Pharmacovigilance Programs in Alberta, Canada [93] 4 Persistence to Inhaled Corticosteroids Latin America [164] Katherine Gooch, Cy Frank, Stuart MacLeod. among Asthmatic Adolescents [153] Juan Camilo Gonzalez R., Thomas Ray (Canada) Lucie Blais, Sylvie Perreault, Djamal Einarson. (Colombia) Berbiche, Johanne Collin, Lyne Lalonde, 94 Estimating Off Label Drug Use in Two Claudine Laurier. (Canada) 16 Adverse Events Following Influenza Pediatric Populations Using Claims Data Vaccination in Adults 50-64 and ≥65 Years: [94] 5 Country’s Illness Burden: Identifying New Vaccine Adverse Event Reporting System Susan A Oliveria, Catherine B Johannes, Drugs of 2004 That Could Help To (VAERS), 7/2002-2/10/2005 [165] Teresa A Simon, William B Saunders, Paul E Overcome It [154] Penina Haber, Herrera Guillermo, Peng-Jun Stang. (United States) Carlos CF Vidotti, Lia LC de Castro, Simone Lu, John Iskander, Kimp Walton, Frank S Calil. (Brazil) DeStefano. (United States) 95 The Cost-Effectiveness of Enhanced Depression Care to Employers [95] 6 Antenatal Use of Corticosteroids: Recall 17 Beers Drugs and Medication Error Reports Amanda R Patrick, Jerry Avorn, Francisca Accuracy in Questionnaires [155] in North Carolina Nursing Homes [166] Azocar, Ronald Kessler, Evette Ludman, Maria Cederholm, Britta Alexandersson, Richard A Hansen, Sandra B Greene, Joyce McCulloch, Gregory Simon, Philip S Helle Kieler. (Sweden) Charlotte E Williams, Susan J Blalock, Wang. (United States) Kathleen D Crook, Roger Akers, Timothy S 7 Use of Antiplatelet Drugs among Carey. (United States) 96 The Norwegian Prescription Database Outpatients with Diabetes at a Medical (NorPD) - New Register for Center in Southern Taiwan [156] 18 Abstract Withdrawn[167] Pharmacoepidemiologic Research Chi Wen Chiang, Hui Fen Chiu, Hsin Lung Covering a Whole Nation [96] Wu, Chun Yuh Yang. (Taiwan) 19 Antihypertensive Drug Use in Diabetic Kari Furu, Hanne Strøm, Marit Rønning, Patients in Japan: A Drug Use Investigation Svetlana Skurtveit, Anders Engeland, Aage 8 A Survey-Based Assessment of the Contrasted with Guidelines [168] Tverdal. (Norway) Prevalence and Severity of Chronic Hand Shingo Horiguchi, Yukari Kamijima, Dermatitis (ChHD) [157] Nobuhiro Ooba, Kiyoshi Kubota, Mitsunori 97 Prevalence and Treatment of Joseph F Fowler, Mei Sheng Duh, Jane Yagame, Shigeru Kageyama, Kazuo Samizo, Hypertensive Patients with Multiple Chang, John Person, Deborah Thorn, Monika Yoshihiro Shimodozono, Tadashi Kusunoki. Cardiovascular Risk Factors in Italy [97] Raut, Arindam Ghosh, Elana Den, Jennifer (Japan) Miriam CJM Sturkenboom, Giampiero Reynolds. (United States) Mazzaglia, Gino Picelli, Essy Mozaffari, 20 Evaluation of Prescribing to Patients with Alessandro Filippi, Claudio Cricelli. 9 Spontaneous Reports on Desmopressin- Coronary Heart Disease Against the (Netherlands) Associated Hyponatremia in Elderly National Service Framework [169] Patients [158] Annie Hutchison, Helen Seaman, Richard 98 Duration of Therapy among Patients Torbjörn Callréus, Elisabet Ekman, Morten Farmer, Corinne de Vries. (United Kingdom) Dispensed Type 2 Diabetes Medications Andersen. (Denmark) in the U.S. and U.K. [98] 21 What Happens When the Drug of Choice Priscilla Velentgas, J Alexander Cole, Najat 10 Abstract Withdrawn Is Temporarily Unavailable? A Report of a Ziyadeh, Laurie Costa, Kathleen Shea, John Natural Experiment in Drug Utilization in D Seeger, Alexander M Walker. (United States) 11 Patients’ Knowledge on Generic a Managed Care Setting in Israel [170] Medications [160] Natan R Kahan, Dan-Andrei Waitman, David Ermelindo Fontes, José C Pimentel, Nelson P Chinitz, Ernesto Kahan. (Israel) Alves, Ana Paula Martins. (Portugal)

END- SESSION A

31 August 21-24, 2005 | Gaylord Opryland Resort and Convention Center | Nashville, TN POSTER SESSION B | TUESDAY, AUGUST 23, 2005

22 Quality Review of Congenital Anomaly 33 What Influence Variation of Sale of 42 Recruiting Physicians to an Internet- Reports Sent to the U.S. Food and Drug Analgesics Containing Codeine between Based Quality Improvement Project: Administration (FDA) [171] Regions in Norway [182] Effectiveness of a Targeted, Multi-Phase, Dianne L Kennedy, Abbie Erickson, Kathleen Svetlana Skurtveit, Anders Engeland, Incentive-Based Strategy [191] Uhl, Roger A Goetsch. (United States) Solveig Sakshaug, Liliana Bachs, Jørgen Jeffrey R Curtis, Angela Becker, Jeroan J Bramness. (Norway) Allison, Linda Casebeer, Mary Elkins, 23 Trends in Use of Varghese George, Catarina Kiefe, Anatachai Clotrimazole/Betamethasone 34 Variation in Antihypertensive Utilisation Panjamapirom, Ramkumar Dipropionate Combination Products in and Guideline Preference [183] Santhanakrishnan, Claire Spettell, Norman Pediatric Patients [172] Pieter Stolk, Boris LG Van Wijk, Eibert R Weissman, Andrew O Westfall, Kenneth G Lois La Grenade, David Moeny, Marilyn R Heerdink, Hubert GM Leufkens. Saag. (United States) Pitts. (United States) (Netherlands) 43 Incidence of Peptic Ulcers during Use of 24 Atypical Antipsychotic and Concomitant 35 Quality Evaluation of Clinical Trial Low-Dose Effervescent Calcium Psychotropic Utilization Patterns in a Literatures on Traditional Chinese Medicine Carbasalate and Regular Low-Dose Schizophrenic Medicaid Population [173] in China from 1980 to 2000 [184] Acetylsalicylic Acid [192] Anthony M Louder, Jeff J Guo. (United Peishan Wang, Zhenlin Jia, Lijian Li, Jiang Martijn G van Oijen, Jeanne P Dieleman, States) Tian, Dengyuan Zhou, Haixin Li. (China) Robert Laheij, Miriam C Sturkenboom, Jan B Jansen, Freek W Verheugt. (Netherlands) 25 Price Trends and Utilization Patterns of 36 Descriptive Analysis, Coded Postoperative Breast Cancer Drug Therapy in the US Ileus, and Medication Utilization of 44 Prescribing of Ethinylestradiol/ Medicaid System [174] Patients Undergoing Bowel Surgery Via Drospirenone to Women on “Watch Lists” Sarah A Malott, Yan Chen, Jane Pruemer, Open Laparotomy [185] of Contraindicated Hepatic, Renal, and Jeff J Guo. (United States) Rachel E Williams, Timothy J Bell, Peter Adrenal Conditions [193] Wang, William B Saunders. (United States) P Mona Eng, Jeanne Loughlin, John D 26 Physician Attitudes and Practice Patterns Seeger, Jennifer A Cutone, Alexander M Concerning Outpatient Antibiotic Use for 37 Report of Post-Marketing Re-Evaluation Walker. (United States) Older Adults [175] by Literature Survey for the Safety of Joshua P Metlay, Judith Kinman, Linda Albendazole [186] 45 The Trade-Off between Cardiovascular and Crossette. (United States) Rong-yuan Zheng, Xue-zhi Yong, Zhen-guo Gastrointestinal Effects of Rofecoxib [194] Zhu, Wei-yong Yin. (China) Stefan R Florentinus, Eibert R Heerdink, 27 Do Psychosocial Factors, Asthma Control Antonius de Boer, Liset van Dijk, Hubert GM and Quality of Life Differ between 38 How Participation in a Drug Company- Leufkens. (Netherlands) Teenagers and Adults? [176] Managed Clinical Trial Influenced GPs’ Jocelyne Moisan, Line Guénette, Yves Guideline Adherence and Drug 46 Pneumonia in an Asthma Cohort in Bolduc, Madone Turcotte, Eileen Dorval, Preference: A Register-Based Study [187] General Practice in the UK [195] Jean-Pierre Grégoire. (Canada) Morten Andersen, Jakob Kragstrup, Jens Luis A Garcia Rodriguez, Mari-Ann Wallander, Soendergaard. (Denmark) Saga Johansson, Ana Ruigomez. (Spain) 28 How and Why Do Men and Women Differ in Medication Usage? [177] 39 Relationship between Conformity to 47 Is It Feasible To Conduct a Cohort Study C Ineke Neutel, Wikke Walop. (Canada) Antidepressant Treatment Guidelines for Via the Internet? [196] Depressive Disorders and Cost of Health Alicia Gilsenan, Patricia Tennis, Elizabeth 29 Utility of Data Mining Methods in Real- Services [188] Andrews, Xiaolei Zhou, Florence Coste, World Pharmacovigilance Setting When Regis Blais, Hana Partlova, Jean Lachaine, Christine Radigue. (United States) Prospectively Compared with Traditional Maida Sewitch. (Canada) Signal Detection Methods [178] 48 Use of Rosuvastatin (Crestor®) after Vaishali K Patadia, G Scott Chandler. 40 The Influence of Physician Guideline Introduction on to the Dutch Market [197] (United States) Compliance on Patient Statin Adherence Myrthe PP Sukel, Wim G Goettsch, Fabian [189] Termorshuizen, Ron MC Herings. (Netherlands) 30 Abstract Withdrawn [179] Joanne R Campione, Betsy Sleath, Andrea K. Biddle, Morris Weinberger (United States) 49 Risk Factors for Inflammatory Bowel 31 Usage of Non-Prescription Medication by Disease in the General Population [198] People with Diabetes in Ahvaz 41 Utilization of Parenteral Non-Steroidal Luis A García Rodríguez, Antonio González- (Khozestan State) [180] Anti-Inflammatory Drugs in the Pérez, Saga Johansson, Mari-Ann Wallander. Shadi Sarahroodi, Mohammad Mehdi Ambulatory Service in Taiwan [190] (Spain) Nourollahi Ravari, Azadeh Ashtarijezhad, Ching-Lan Cheng, Shih-Chen Kuo, Shu-Wen Fatemeh Jahanbakhsh Sefidi. (Islamic Jia, Yea-Huei Yang Kao. (Taiwan) 50 Case-Control Study on Analgesics and Republic of Iran) Nephropathy (SAN). Preliminary Results (2004) [199] 32 Medicaid High-Risk COPD Population: Fokko van der Woude, Lothar AJ Health Care Resource Utilization [181] Heinemann, Helmut Graf, Michael Lewis, Fadia T Shaya, Antoine C El Khoury, Doerthe Kuhl-Habich. (Germany) C.Daniel Mullins, Steven M Scharf. (United States)

32 21st ICPEInternational Conference on Pharmacoepidemiology & Therapeutic Risk Management POSTER SESSION B | TUESDAY, AUGUST 23, 2005

51 Investigation of Deaths and Serious 60 Bacteremia in Patients with Hematologic 69 Trends in Cholesterol Concentrations and Illnesses Following Influenza Vaccination Malignancies: The Impact of Inappropriate the Use of Statins in the Tayside in a Long-Term Care Facility [200] Empirical Antibiotic Treatment on 7-Day Population, 1993-2002 [218] Alison M Rue, Shauna Lyn, John K Iskander, and 30-Day Mortality [209] Li Wei, Thomas M MacDonald, Michael J Joel Bloestein, Paul Gargiullo, Sean Mette Nørgaard, Heidi Larsson, Gitte Murphy. (United Kingdom) Shadomy, Jane Seward, Robert T Chen. Pedersen, Henrik C Schønheyder, Henrik T (United States) Sørensen. (Denmark) 70 Safety Profile of Tiotropium Used in General Practice in England: Results of a 52 Comparison of the Incidence Rates of 61 Risk Factors for Peptic Ulcer Bleeding Prescription-Event Monitoring Study [219] Thromboembolic Events Reported for and Perforation with Celecoxib and Other Lynda V Wilton, Saad A Shakir. (United Patients Prescribed Rofecoxib and Celecoxib Nonsteroidal Anti-Inflammatory Drugs Kingdom) in General Practice in England Using [210] Prescription-Event Monitoring Data [201] M Kay Patterson, Xiaochun Zhang, Jennifer 71 Respiratory Failure in Patients with Rachna Kasliwal, Scott Harris, Deborah Cutone, Jordi Castellsague, Alexander M Myasthenia Gravis in the US [220] Layton, Lynda Wilton, Saad Shakir. (United Walker. (United States) Jasmanda H Wu, Mary N Haan, Wanju S Dai. Kingdom) (United States) 62 Prevalence and Predictors of 53 Potential Limitations of Electronic Antidepressant Utilization before, during 72 Longitudinal Patterns of Asthma Database Studies of Non-Aspirin Non- and after Pregnancy: A Population-Based Medication Use in Preschool Children: Steroidal Anti-Inflammatory Drugs Study [211] Results from the PIAMA-Study [221] (NANSAIDs) and Risk of Myocardial Élodie Ramos, Djamal Berbiche, Évelyne Mira GP Zuidgeest, Henriette A Smit, Infarction (MI) [202] Rey, Lucie Blais, Anick Bérard. (Canada) Madelon Bracke, Alet Wijga, Bert Leonard Ilkhanoff, James D Lewis, Sean Brunekreef, Hubert GM Leufkens. Hennessy, Jesse A Berlin, Stephen E 63 Consequences of Immunosuppression (Netherlands) Kimmel. (United States) Minimization Following Diagnosis of Gastrointestinal Complications in Renal 73 Validation of Drug Use as Proxy 54 Nausea and Vomiting in Pregnancy Transplant [212] Identifier of Congestive Heart Failure (NVP): What Is the Impact of Race and Mark A Schnitzler, Karen L Hardinger, Diagnosis [222] Ethnicity? [203] Thomas E Burroughs, William Irish, Krista L Annette B Beiderbeck, Maurille A Feudjo- Anais Lacasse, Evelyne Rey, Ema Feirerra, Lentine, Daniel C Brennan. (United States) Tepie, Samantha A St.Laurent, Nawab Caroline Morin, Djamal Berbiche, Anick Qizilbash. (United Kingdom) Bérard. (Canada) 64 Inhaled ß-Agonists and the Risk of Sudden Cardiac Death [213] 74 Reliability of an Adverse Drug Event 55 Association between beta-Agonists and Sabine MJM Straus, Miriam CJM Classification System for In-Hospital Death in Patients with Chronic Airway Sturkenboom, Gysèle S Bleumink, Jeanne P Pharmacovigilance [223] Disease [204] Dieleman, J Herre Kingma, Johan van der Kevin Haynes, Sean Hennessy, Knashawn Odile Sheehy, Jean Bourbeau, Jacques Lei, Bruno HCh Stricker. (Netherlands) Morales, Catherine Barnhart, Gene Gibson, LeLorier. (Canada) Chitra Jaipaul, Darren Linkin. (United States) 65 Tranexamic Acid, Menorrhagia and Venous 56 Health Outcomes in Women Taking Thromboembolism - A Case-Control Study 75 Evaluating Short-Term Drug Effects in Ethinylestradiol/Drospirenone and Other Using the GPRD [214] Claims Data Using a Physician-Specific Oral Contraceptives, Interim Results [205] Anders Sundstrom, Helen Seaman, Lars Prescribing Preference as an Jeanne Loughlin, John D Seeger, P Mona Alfredsson. (Sweden) Instrumental Variable [224] Eng, C Robin Clifford, Alexander M Walker. M Alan Brookhart, Philip Wang, Daniel H (United States) 66 Hormone Replacement Therapy and Risk Solomon, Sebastian Schneeweiss. (United of Colorectal Cancer: A Population-Based States) 57 Safety Profile of Pimecrolimus Cream as Case-Control Study [215] Used in General Practice in England: Mette S Tetsche, Heidi Larsson, Mette 76 A Method of Assigning Severity of Interim Results of an Ongoing Nørgaard, Søren Friis, John A Baron, Henrik Chronic Obstructive Pulmonary Disease Prescription-Event Monitoring Study [206] T Sørensen. (Denmark) Using Administrative Data [225] Vanessa Marshall, Lynda V Wilton, Saad AW Suellen M Curkendall, Stephan Lanes, Shakir. (United Kingdom) 67 The Association between Antiepileptic Cynthia de Luise, Mary Rose Stang, Earl Drug Use and Aplastic Anemia [216] Goehring, Jr., Dewei She, Judith K Jones. 58 Significant Association between Previous Patricia MLA van den Bemt, Patrick C (United States) and Future Asthma Exacerbations in Souverein, Tjeerd P van Staa, Ron HB Severe or Difficult-to-Treat Asthma [207] Meyboom, Wouter W van Solinge, Toine CG 77 Abstract Withdrawn [226] Mary K Miller, Beiyao Zheng, Howard Fox, Egberts, Bert GM Leufkens. (Netherlands) June Lee, Sally Wenzel. (United States) 78 Medication and Pharmacological 68 Fifteen Additional Months of Follow-Up Treatment of Nausea and Vomiting of 59 Cardiovascular Safety of Viagra® Confirm the Absence of Association Pregnancy: An Unmet Need? [227] (Sildenafil Citrate): Results of the between Immunization with Charles Piwko, Michael Iskedjian, Olivier International Men’s Health Study, a Long- Infanrix™hexa and Sudden Unexpected Desjardins, Thomas R Einarson. (Canada) Term Observational Cohort Study [208] Deaths [217] Murray A Mittleman, Michael Lewis, Malcolm Thomas Verstraeten, Corinne Pierfitte, K Maclure, Gillian C Hall, Nicholas Moore, Thomas Breuer. (Belgium) Rachel E Sobel, Robert F Reynolds, Dale B Glasser. (United States) 33 August 21-24, 2005 | Gaylord Opryland Resort and Convention Center | Nashville, TN POSTER SESSION B | TUESDAY, AUGUST 23, 2005 POSTER SESSION C

79 Evaluation of Brighton Collaboration 90 Bullying and Medicine Use among 1 Drug Utilization Review of Losartan at Standardized Case Definitions: Adolescents: Cross-Sectional Survey [239] Outpatient Clinics in Sultan Qaboos Sensitivity, Specificity, Reliability, and Bjorn E Holstein, Pernille Due, Ebba H University Hospital, Oman [282] Applicability for Intussusception, Fever, Hansen. (Denmark) Waiel H Al-Naeem, Kassim A Al-Riyamy, and Persistent Crying [228] Ragini Vashnave. (Oman) Katrin S Kohl, Manya Magnus, Jane Gidudu, 91 Does Incorporating Medications in the Jonathan Li, Robert Ball, Saad B Omer, Neal Surveyors’ Interpretive Guidelines Reduce 2 Use of Prescription Cyclo-Oxygenase 2 Halsey, Sean Shadomy, Thomas A Farley. the Use of Potentially Inappropriate Inhibitors (COX-2) and Non COX-2 Non- (United States) Medications in Nursing Homes? [240] Steroidal Anti-Inflammatory Drugs Kate L Lapane, Brian J Quilliam, Steve (NSAID) in a UK Population [283] 80 Visual Distortions of Relative Risk and Kogut, David Dore, Carmel M Hughes. Felix M Arellano, Charles E Wentworth, Odds Ratio in Graphical Figures Published (United States) Corey May, Anila Verma, Elena Rivero, in the Medical Literature [229] Kenneth J Rothman. (United States) Mitchell AH Levine, Ahmad El-Nahas. 92 Drug Expenditures among Elderly People (Canada) in Belo Horizonte, Brazil [241] 3 Abstract Withdrawn [284] Marina G Lima, Andreia Q Ribeiro, Suely 81 Adjusting for Physician Sampling When Rozenfeld, Carlos H Klein, Francisco A 4 Trends in Antihypertensive Drug Prescribing Calculating Reporting Rates [230] Acurcio. (Brazil) in Internal Medicine Departments in Italy Rita Ouellet-Hellstrom. (United States) from 1998 to 2003 [285] 93 Cost-Effectiveness in the Prevention of Giovanna Cipolla, Mariagrazia Felisi, Simona 82 Peripheral Ischaemia and Gemcitabine - Cerebral Infarction and Myocardial Ravera, Andrea Lanza, Cristina Meneghin, An Assessment of the Strength of Infarction by Folic Acid Intake — Taking Ambrogio Bottoni, Giovanbattista Ippoliti, Association [231] Genetic Screening into Account [242] Gianmario Frigo. (Italy) Catharine E Raitt, Andrzej Czarnecki. Katsunori Masaki, Koichi Miyaki, Shunya (United Kingdom) Ikeda, Kazuyuki Omae. (Japan) 5 Drug Therapy Follow-Up for Hypertensive Patients at a Senior Community Center in 83 Different Results from Different Causal 94 Meta-Analysis of the Causal Relationship Campo Grande, Mato Grosso do Sul, Brazil Contrasts in the Presence of Effect between Coffee Consumption and Type 2 [286] Modification [232] Diabetes Mellitus [243] Maria L Oshiro, Eliza M Novaes, Lia LC Til Stürmer, Kenneth J Rothman, Robert J Hideki Origasa, Naomi Yokoyama, Hironori Castro. (Brazil) Glynn. (United States) Sakai, Mitsuhiko Noda. (Japan) 6 Preventable Medical Errors Involving Mix- 84 Abstract Withdrawn[233] 95 A Meta-Analysis of Randomized Up of Tuberculin Purified Protein Controlled Trials with Paroxetine: Does Derivative (PPD) and Vaccine Products 85 Antidiabetic Drug Treatment Patterns and Putative Mode of Action Really Improve Reported to the Vaccine Adverse Event Glycemic Control in a U.S. Managed Care Clinical Outcomes? [244] Reporting System (VAERS) and Adverse Population [234] Martin Katzman, Andrea C Tricco, Diane Event Reporting System (AERS) [287] Susan E Andrade, Cynthia Willey, Joseph McIntosh, Marie-Josee Filteau, Pierre Bleau, Soju Chang, Vitali Pool, Kathryn O’Connell, Cohen, Jerry H Gurwitz. (United States) Pratap Chokka, Kevin Kjernisted, Ba’ D Jacquelyn Polder, John Iskander, Colleen Pham, Hiram Mok. (Canada) Sweeney, Robert Ball, M Miles Braun. 86 Post-Marketing Safety Surveillance Studies (United States) Requiring Access to Patients and Charts: 96 Local Collaborations Independently Does Persistence Yield Results? [235] Affect the Provision of Community 7 Descriptive Analysis of Newly Diagnosed Alicia Gilsenan, Elizabeth Andrews, Alki Pharmacy Services to Patients Performing Overactive Bladder Patients Using a Burdett, Rebecca Martin. (United States) Self-Monitoring of Blood Glucose [245] Claims Database [288] Michiel J Storimans, Olaf H Klungel, Herre Anne B Dilley, Jean M Hastie, Susan A Hall, 87 Health Economic Analyses in South Talsma, Marcel L Bouvy, Cornelis J de Blaey. Peter J Egger. (United States) America: Analysis of the Literature [236] (Netherlands) Marcio Machado, Thomas R Einarson, 8 Changes in Blood Pressure Lowering Michael Iskedjian. (Canada) 97 Association between Atypical Treatment: Do We Reach Treatment Goals? Antipsychotic Drug Use and Tardive The Tromsø Study 1994 and 2001 [289] 88 Discontinuation Rates for SSRIs and Dyskinesia Assessed by an Empirical Anne Elise Eggen, Inger Njolstad, Frode Other Second-Generation Antidepressants Bayes Signal Detection Method Applied Skjold. (Norway) in Outpatients with Major Depressive to FDA’s Adverse Event Reporting System Disorder. A Systematic Review and Meta- (AERS) Database [246] 9 ARAMIG Study: Correlates of Use of Analysis [237] Huei-Ting Tsai, Ana Szarfman, Joseph Antimigraine Therapy in French Family Gerald Gartlehner, Rick A Hansen, Kathleen Tonning, Jonathan G Levine, P Murali Practice [290] N Lohr, Bradley N Gaynes, Timothy S Carey. Doraiswamy. (United States) Eric Van Ganse, Dominique Huas, Gerard (United States) Mick, AF Gaudin, G Nachbaur, Nadine 98 Drug Consumption in the Nordic Desmons, Abdelkader El Hasnaoui. (France) 89 Abstract Withdrawn[238] Countries between 1999 and 2003 [247] Tinna J Voipio, Pirkko K Paakkari, Erkki S 10 Use of N-of-1 Trials in Stimulant-Treated Palva. (Finland) Youths in The Netherlands [291] Adrianne Faber, Ron Keizer, Paul B van den Berg, Lolkje TW de Jong-van den Berg, END- SESSION B Hilde Tobi. (Netherlands) 34 21st ICPEInternational Conference on Pharmacoepidemiology & Therapeutic Risk Management POSTER SESSION C | WEDNESDAY, AUGUST 24, 2005

11 Characteristics of End Stage Renal 20 Identification of Adverse Events in 29 A Naturalistic One Year Prospective Study, Disease Patients Receiving Phosphate Inpatients: Results of a Preliminary Concerning Patients Suffering from Binder Therapy in UK Primary Care [292] Survey in Japan [301] Schizophrenia (DSM-IV) and Treated with Arlene M Gallagher, Heba Elgazzar, Gwenda Shunya Ikeda, Mia Kobayashi, Hideto Sakai. Antipsychotic Drugs [310] Hughes. (United Kingdom) (Japan) Martin Patrick, Massol Jacques, Dalery Jean, Hardy-Bayle Marie-Christine, Gury Charles, 12 Application of Disproportionality 21 Prevalence and Patterns of Prescriptions Peretti Charles-Siegfried. (France) Analysis to Spontaneous Reports of with Potentially Fatal Cardiotoxic Drug Fluroquinolone Phototoxicity: Correlation Interactions: A Population-Based Study 30 Reliability of Informations about Drug of Reporting Rates with Drug Molecular of Ambulatory Patients in Taiwan [302] Utilization by Retired People, from Postal Structure Toxicity Gradients [293] Yea-Huei Kao Yang, Shu-Wen Jia, Shih-Chen and Domiciliary Surveys in Belo Manfred Hauben, Charles Gerrits, Lester Kuo, Ching-Lan Cheng. (Taiwan) Horizonte/MG, Brazil [311] Reich. (United States) Andreia Q Ribeiro, Cibele C Cesar, Suely 22 Prevalence of Hormone Replacement Rozenfeld, Carlos H Klein, Francisco A 13 Retrospective Disproportionality Analysis Therapy in Japan before and after the Acurcio. (Brazil) on Phantom Ships (Discounted Drug-Event Publication of the Study Results from Associations Originally Identified through WHI. Japan Nurses’ Health Study [303] 31 Changes in the Prevalence and Incidence Traditional Pharmacovigilance) [294] Tomoko Kodama, Kota Katanoda, Toshiharu of Coronary Heart Disease in the UK Manfred Hauben, Lester Reich, Charles M Fujita, Shosuke Suzuki, Hideki Mizunuma, between 1992 and 2001 [312] Gerrits, Eugene P van Puijenbroek. (United Takeshi Aso, Kunihiko Hayashi. (Japan) Helen E Seaman, Annie Hutchison, Richard DT States) Farmer, Corinne S de Vries. (United Kingdom) 23 Use and Compliance of Bisphosphonates 14 Period Prevalence of Four Autoimmune 1993-2003 in Funen County, Denmark. A 32 Adverse Event Onset Versus FDA Receipt Diseases within a Large US Managed Care Population Based Study [304] Date in the FDA SRS/AERS Database [313] Population [295] John Larsen, Palle M Christensen, Morten Atsuko Shibata, Daniel Furst, Hal Paulus, Earl L Goehring, Jr., Bao-Anh Nguyen-Khoa, Andersen. (Denmark) Haiying Liu, Sean Zhao, Alexander Ruggieri, Ruby M Vendiola, Pavel Napalkov, Wei Dong, James Louie, Wayne Wallis. (United States) Judith K Jones. (United States) 24 Results of a Physician Survey To Evaluate Compliance with the Product Label 33 Triptan Use in Denmark 1992 – 2001: A 15 What Is the Proportion of Recommendation for Potassium Population Based Register Study [314] Hospitalizations Related to ADRs in Monitoring [305] Jens Sondergaard, Soren Rathje, Morten Portugal? [296] Jeanne Loughlin, John D Seeger, P Mona Andersen. (Denmark) José P Guerreiro, José Giria, Filipa Costa, Eng, Kelly Oh, Alexander M Walker. (United Ana P Martins, Ana C Miranda. (Portugal) States) 34 Patterns of Outpatient Services and Prescription Utilization for Diabetes 16 Comparison of the Nature of 25 Herbal Drug Utilization by Retired among Recipients with Diabetes with Spontaneous Adverse Drug Reaction People: Results from Domiciliary Survey Versus without Comorbid Depression in a Reports Received from Consumers Versus in Belo Horizonte/MG, Brazil [306] Medicaid Population [315] Healthcare Professionals in 2003 [297] Lucianno DP Marliere, Andreia Q Ribeiro, Murali Sundaram, Michael Smith. (United Isaac W Hammond, Donna Rich, Lisa Laksh, Maria GL Brandao, Suely Rozenfeld, Carlos H States) Andrew G Cochrane, Vlasta Pinkston, Trevor Klein, Francisco A Acurcio. (Brazil) G Gibbs. (United States) 35 Adverse Event Reports among the Elderly 26 Prevalence and Costs Associated with [316] 17 Cardiovascular Risk Profile Distribution in a Treating Depression with Painful Physical Sheila R Weiss, Robert J LoCasale, Jr.. Norwegian Population According to Symptoms in a Canadian Administrative (United States) European (SCORE) Guidelines: Implications Health Services Database [307] for Pharmacological Primary Prevention. Alki N Burdett, Charlotte C Gard, Alicia 36 Impact of Cautionary Messages on Coxib The Tromsø Study 2001 [298] Gilsenan, Zeenat Hirji, Joel Raskin, David P Utilization [317] Ingeborg Hartz, Inger Njølstad, Anne Elise Miller. (United States) Donald Willison, Deborah A Marshall, Nathalie Eggen. (Norway) A Kulin, Muhammad Mamdani. (Canada) 27 Characteristics of Vertebroplasty Patients: 18 Communication of Findings and An Analysis of Claims Data from a Large 37 German, Dutch and US Differences in Conclusions in Pharmacovigilance: Need Not-For-Profit Healthcare Insurer [308] Psychotropic Medication Prevalence for for Precision [299] Amy S Mudano, John Bian, Sarah Sampsel, Youths [318] Manfred Hauben, Lester Reich. (United States) Mary Elkins, Dow Briggs, Alan Neal, Judy Julie M Zito, Daniel J Safer, Hilde Tobi, Cope, Tom Gross, Dan McGunagle, Jove Katrin Janhsen, L.T.W. de Jong-van den 19 Lifetime Co-Occurrence of Illicit Graham, Ann Ferriter, Kenneth G Saag. Berg, Joerg M Fegert, Mikhail Menis, Gerd Prescription Drug Use Disorders with Other (United States) Glaeske. (United States) Illicit Drug Use Disorders, Alcohol Use Disorders and Mental Disorders [300] 28 Linking Symptoms Severity and 38 Relationship between Serotonergic Boji Huang, Deborah A Dawson D, Bridget F Diurnality to Productivity Loss - A New Antidepressants and Worsening of Grant, Frederick F Stinson FS, Patricia S Conceptual Approach [309] Parkinson’s Disease [319] Chou, Tulshi Saha, Rise B Goldstein, Sharon Robert J Nordyke, Daniel Aguilar, Albert Maurits EL Arbouw, Kris LL Movig, Cees M Smith, June W Ruan, Roger P Pickering. Lee, Amitabh Singh, Michael Tedeschi. Neef, Henk-Jan Guchelaar, Toine CG Egberts. (United States) (United States) (Netherlands)

35 August 21-24, 2005 | Gaylord Opryland Resort and Convention Center | Nashville, TN POSTER SESSION C | WEDNESDAY, AUGUST 24, 2005

39 Impact of Variation in Interviewer Skill- 48 Cardiovascular Risk Factors at Baseline in 59 HIV-Infected Patients Presenting Adverse Sets and Work Organization on Odds Users of Coxibs Compared to Users of Effects (AE) Associated with Highly Ratios in an Interview Based Case- NSAIDs [329] Active Antiretroviral Therapy (HAART): A Control Study [320] Romy B de Jong, Nancy S Breekveldt-Postma, Survey over an 18-Month Period [340] Kerstin J Blomgren, Anders Sundstrom, Gunnar Wim G Goettsch, Ron MC Herings. (Netherlands) Aurelie Molia, Fabien Vitry, Christophe Steineck, Bengt-Erik Wiholm. (Sweden) Strady, Isabelle Beguinot, Jean-Luc Berger, 49 Incidence of Malignant Neoplasm in Growth Anne Waldner, Christine Rouger, Thierry 40 Evaluating the Impact of the American Hormone Deficient (GHD) Children Treated Trenque. (France) Academy of Pediatrics (AAP) and U.S. with Recombinant Growth Hormone (GH). Public Health Service (USPHS) 1999 KIGS Registry [330] 60 Use of Hormone Replacement Therapy and Joint Recommendation to Temporarily Lia P Gutiérrez, Andrew R Maguire, Anders F Risk of Non-Hodgkin Lymphoma [341] Delay Newborn Hepatitis B Vaccination Mattsson, Patrick Wilton, On Behalf of the Mette Nørgaard, Aslak H Poulsen, Henrik Due to Thimerosal Content, Using KIGS International Board. (Spain) Gregersen, Søren Friis, Marianne Ewertz, Automated Data [321] Hans E Johnsen, Henrik T Sørensen. Soju Chang, Elizabeth Begier, Stephanie D 50 Psychotropic Drug Use Patterns in Youths (Denmark) Schech, Patricia Venus, Deborah Shatin, M with Anticonvulsants Therapy: A Study Miles Braun, Robert Ball. (United States) from the Netherlands [331] 61 The Impact of Compliance with Statin on Yingfen Hsia, Paul van den Berg, Corinne S Coronary Artery Disease (CAD) Rate for 41 Aspirin and Nonsteroidal Anti- de Vries, Lolkje de Jong-van den Berg, Primary Prevention [342] Inflammatory Drugs and Risk of Hilde Tobi. (Netherlands) Marie Hélène Bouchard, Alice Dragomir, Hemorrhagic Stroke: Acute Brain Sylvie Perreault. (Canada) Bleeding Analysis Study [322] 51 Galactorrhoea and Antipsychotic Nam-Kyong Choi, Seung-Mi Lee, Byung-Woo Medication: Data from the AMSP Project 62 Self-Reported Medication Adherence in a Yoon, Byung-Joo Park. (Korea) [332] Population-Based Sample of Young Stefan Kropp, Eveline Jaquenoud Sirot, African Americans and Whites: The CAR- 42 Weight Gain and Diabetes as a Side Andreas Horvath, Renate Grohmann. DIA Study [343] Effect of Psychiatric Medications [323] (Switzerland) Maribel Salas, O Dale Williams, John Bian, Norbert Dahmen, Andreas Horvath, Eveline Pamela J Schreiner, Lucia Juarez, Yongin Jaquenoud, Renate Grohmann. (Germany) 52 The Management and Outcomes of Kim, Sharina D Person, Catarina Kiefe. Patients Prescribed Pioglitazone in (United States) 43 Risk of Osteoporosis/Osteopenia among Primary Care in England. A Study of the Women with Breast Cancer Receiving Clinical Risk Management of Selected 63 Abstract Withdrawn [344] Anti-Cancer Therapy (ACT) [324] Adverse Events [333] Simone Peart Boyce, Mei Sheng Duh, Rachna Kasliwal, Lynda Wilton, Saad Shakir. 64 Prescription of Drugs during Pregnancy – Monika Raut, Jane Bradman, Edith A Perez, (United Kingdom) What Is Going on in Russia? [345] Betty A Mincey, Maryna Marynchencko. Leonid S Stratchounski, Elena A Strizhenok. (United States) 53 Inappropriate Drug Use in the Very Old – (Russian Federation) Temporal Trends [334] 44 Matched Retrospective Cohort Study of Inga Klarin, Johan Fastbom, Anders Wimo. 65 Determinants of Switching between Two Breast Cancer Incidence among Initiators (Sweden) Drugs [346] of Racemic Zopiclone, Temazepam, and Hani M Tamim, Jacques LeLorier. (Canada) Zolpidem in the General Practice 54 Macrolide Antibiotics during Pregnancy Research Database [325] in Relation to Pyloric Stenosis [335] 66 Abstract Withdrawn[347] P Mona Eng, Najat Ziyadeh, Beth L Yoonsook Lee. (United States) Nordstrom, Judy Caron, David Amato, John 67 Rates of Serious Vascular Events among D Seeger. (United States) 55 Barriers to the Use of Adjuvant Patients Dispensed Type 2 Antidiabetic Chemotherapy in Stage III Colorectal Medications in the U.S. and U.K. [348] 45 Mortality and Vascular Events in Patients Cancer [336] Priscilla Velentgas, J Alexander Cole, Laurie with Thyroid Dysfunction [326] Samuel M Lesko, Trudy Coleman. (United States) Costa, Najat Ziyadeh, Kathleen Shea, John Robert WV Flynn, Thomas M MacDonald, D Seeger, Alexander M Walker. (United Roland T Jung, Andrew D Morris, Graham P 56 Demographic, Environmental, and Genetic States) Leese. (United Kingdom) Predictors of Metabolic Side Effects of Hydrochlorothiazide Treatment in 68 No Increase of Sudden Unexpected 46 Indications, Efficacy and Tolerance of Hypertensive Subjects [337] Deaths Following Immunization with High Doses of Ropinirole – Results of a Anke H Maitland-van der Zee, Stephen T Infanrix™ 4- and 5-valent Combination French Field Study (CURE) [327] Turner, Gary L Schwartz, Arlene B Chapman, Vaccines [349] Anne-Francoise Gaudin, Herve Allain, Olaf H Klungel, Eric Boerwinkle. Thomas Verstraeten, Corinne Pierfitte, Valerie Assuerus, Olivier Blin, Alain Destee, (Netherlands) Thomas Breuer. (Belgium) Olivier Rascol, Francois Tison, Marie Vidailhet, Abdelkader El Hasnaoui. (France) 57 Abstract Withdrawn [338] 69 Compliance and Outcomes amongst Patients Being Treated for Both 47 Changes in Use of Cardiovascular Drugs 58 Abstract Withdrawn [339] Hypertension and Raised Lipid [350] at the End of Life [328] Li Wei, Thomas M MacDonald. Robert J Glynn, Sebastian Schneeweiss, Til (United Kingdom) Sturmer, Philip S Wang, Jerry Avorn. (United States) 36 21st ICPEInternational Conference on Pharmacoepidemiology & Therapeutic Risk Management POSTER SESSION C | WEDNESDAY, AUGUST 24, 2005

70 Maternal Asthma and Risk of 80 Measuring Change in Drug Utilization [361] 91 Decrease in Health Care Resource Hypospadias [351] John A Mandryk, Judith M Mackson, Fiona E Utilization (HCRU) by Patients Started on Henrik Toft Sørensen, Lars Pedersen, Mette Horn, Sonia E Wutzke, Lynn M Weekes. Olanzapine for Treatment of Bipolar Nørgaard, Pia Wogelius, Kenneth J (Australia) Affective Disorder (BPD) Using Régie De Rothman. (Denmark) L’assurance Maladie Du Québec (Ramq) 81 Assessing the Costs of Hepatitis A Food Administrative Databases [372] 71 Antipsychotic-Induced Involuntary Related Interventions: Methodological Odile Sheehy, Deborah A Marshall, Nicole Movement Disorders: A Four-Year Challenges [362] Brazier, Stuart MacLeod, Jacques LeLorier. Inpatients Survey in Taiwan [352] Andrea C Tricco, Ba’ D Pham, Bernard Duval, (Canada) Shu-Yu Yang, Yea-Huei Kao Yang, Yi-Hsin Vladimir Gilca, David Moher. (Canada) Yang, Mian-Yoon Chong. (Taiwan) 92 Reduced Pulmonary Function in Subjects 82 Discontinuation of Aspirin, Warfarin and with Diabetes Mellitus [373] 72 Quality of Life Improvements with Clopidogrel, and Stroke Recurrence in Mark Ma, Indiana Strombom, Jeffrey Olopatadine Nasal Spray Treatment of Medicaid Patients [363] Ferguson, Frank Delisle, Kenneth Seasonal Allergic Rhinitis: Pooled Fadia T Shaya, Antoine C El Khoury, Hugh Hornbuckle. (United States) Analysis of Two Randomized Controlled Fatodu, Matthew R Weir. (United States) Trials [353] 93 Unique Clinical Trial Design To Assess the Carol J Fairchild, Michael G Wall, Michael 83 Time to Maximum Reporting Rate (TMRR) Efficacy of a Drug for Erectile Brubaker, Margaret Drake. (United States) and Time to Reversal of Reporting Rate Dysfunction in Various Populations [374] (T3R) Are Useful in Post Marketing Craig Donatucci, Irwin Goldstein, Geoffrey 73 The Validity of Using Pharmacy Records Signal Detection [364] Sklar, Fanni Natanegara, Ann Cameron, for Assessing the Retention Time of Drug Swapu Banerjee, Bharat Thakrar. (United David G Wong, Sanjeev Ahuja. (United States) Therapy [354] Kingdom) Pieter D Knoester, Mirjam Heins, Yechiel A 94 Cost-Effectiveness Analysis of Treatment Hekster, Toine CG Egberts. (Netherlands) 84 A Study of the Quality of Information Strategies for Heparin-Induced Provided in Serious Adverse Event Thrombocytopenia [375] 74 Disability Measures in Stroke: Score Reports in Cancer Clinical Trials [365] Amanda R Patrick, Jerry Avorn, Wolfgang C Conversion between the Barthel Index Jennifer Watts, Brenda Kowaleski, Andrew Winkelmayer, Michael A Fischer. (United and the Motor Component of Functional Arnold. (Canada) States) Independence Measure for Practitioner [355] 85 Nurses as Reporters of Adverse Drug 95 Epidemiological Research & Canadian Health Sooyeon Kwon, Pamela W Duncan. Reactions. A Link between the Health Databases - A Systematic Review [376] (United States) Care System and Regional Centres of Andrea C Tricco, Ba' D Pham, Nigel SB Pharmacovigilance [366] Rawson, Reid C Robson. (Canada) 75 A Simulation Program for Martin Backstrom, Elisabet Ekman. (Sweden) Epidemiologists, by Epidemiologists 96 Prevalence and Treatment of [356] 86 Meta-Analysis of Effect of Integrated Hypertensive Patients with Multiple Ulka B Campbell*, Nicolle M Gatto*, Susan Traditional Chinese Medicine and Western Concomitant Cardiovascular Risk Factors E Hodge. (United States) Medicine on SARS Treatments [367] in the Netherlands [377] Yan Chen, Jeff J Guo. (United States) Miriam CJM Sturkenboom, Jeanne P 76 Estimation of Hazard Functions for Dieleman, Gino Picelli, Essy Mozaffari, Adverse Events of Anti-Cancer Drug TS-1- 87 Parents Report on Stimulant Treatment in Marjolein Pompen, Johan van der Lei. Application of a Mixed Log-Logistic the Netherlands: Initiation and Follow- (Netherlands) Model for Interval Censored Data- [357] Up Care [368] Akira Fukushima, Wataru Kashiwagi, Masaki Adrianne Faber, Luuk J Kalverdijk, 97 Rates and Characteristics of Suicide Sano, Chikuma Hamada, Isao Yoshimura. Jacqueline G Hugtenburg, Ruud B Minderaa, Attempt Cases among Users of (Japan) Lolkje TW de Jong-van den Berg, Hilde Antidepressants in Managed Care: A Tobi. (Netherlands) Seven-Year Case Series, 1997-2003 [378] 77 Abstract Withdrawn [358] Robert J Valuck, Anne M Libby, Richard R 88 How Is Non-Prescription Emergency Oral Allen. (United States) 78 Validation of Thai Community Hospital Contraception Being Used in Portugal? Databases for Health Policy Evaluations [369] on Hospital Drug Utilization [359] José P Guerreiro, Maria J Branco, Baltazar Penkarn Kanjanarat, Almut G Winterstein, Nunes, Vera Gouveia. (Portugal) Earlene Lipowski, Abraham G Hartzema. (United States) 89 Under-Reporting of Adverse Drug Reactions: A Systematic Review [370] 79 Consistency of Signal Detection Measures Lorna Hazell, Saad AW Shakir. (United with Effect Measures in Epidemiology [360] Kingdom) Tetsushi Komori, Takashi Ohmori, Tosiya Sato. (Japan) 90 Hepatic Safety of Pegvisomant: An Example of Effective Lifecycle Risk Management Strategy [371] Douglas E Kargman, Ferdinando E Vegni. (United States) END- SESSION C

37 August 21-24, 2005 | Gaylord Opryland Resort and Convention Center | Nashville, TN